Arkolith/Insider Trading/TLSI/Form 4

Devlin Jodi

Chief of Clinical OperationsTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed Mar 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)273$4.12$1K97K
Mar 12, 2026Sell(S)2K$4.09$7K98K
Mar 11, 2026Sell(S)1K$4.13$5K99K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-020190) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML